All Interventions

    Neurofeedback

    Devices
    Brain Training

    Real-time brain wave training using EEG feedback to optimize neural patterns for focus, calm, sleep, and performance.

    Evidence Summary

    6
    / 10Score
    Moderate
    Moderate Evidence

    Best evidence is in childhood ADHD. A 2025 meta-analysis of 17 RCTs (939 children) found neurofeedback training significantly improved inhibitory control (p<0.0001) and working memory (p<0.05), with larger and more durable gains when total training exceeded roughly 1,260 minutes; a 2026 network meta-analysis (37 RCTs, 2,922 youth) ranked neurofeedback highest among digital interventions for reducing inattention (SUCRA 79.4%). Evidence outside pediatric ADHD is weaker and mixed: a 2025 Lancet Psychiatry adult-ADHD network meta-analysis found non-pharmacological effects inconsistent across raters, and a 2024 meta-analysis of 7 RCTs found no added benefit over control conditions for self-perceived sleep quality or insomnia. Protocol specificity and provider quality remain critical. Educational information, not medical advice.

    Evidence Scale

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    AnecdotalStrong RCT

    Mechanism of Action

    EEG sensors measure cortical rhythms in real time, and software rewards the brain when target patterns are produced (for example increased sensorimotor rhythm/beta or a reduced theta/beta ratio). Through operant conditioning the brain gradually learns to self-regulate toward states associated with sustained attention, calm, or sleep. Benefits appear dose-dependent and, for some outcomes such as working memory and inhibitory control, can persist after training ends.

    Who Is This For?

    Focus/attention issues, anxiety, PTSD, sleep optimization, peak performance, cognitive enhancement.

    Protocol & Dosing

    Dose

    30-60 minute sessions. 20-40 sessions typical protocol.

    Frequency

    2-3x/week

    Duration

    20-40 session course

    Protocol Summary

    EEG sensors are applied to the scalp; sessions run 30-60 minutes, typically 2-3x per week for a 20-40 session course. Emerging meta-analytic data suggest cumulative training beyond roughly 1,260 minutes (about 20+ hours) yields larger and more sustained gains in working memory and inhibitory control. Protocol is matched to the goal (e.g., SMR/theta-beta for focus, alpha for relaxation, alpha-theta for trauma) under qualified supervision.

    Interactions & Precautions

    Contraindications

    • Seizure disorders (some protocols)
    • Severe psychiatric conditions (supervision needed)

    Potential Risks

    • •Provider quality variation
    • •Cost
    • •Time commitment

    Potential Side Effects

    Temporary fatigue
    Rare: temporary symptom increase

    Practitioner Notes

    Clinical annotations from Dr. Goel

    Set expectations by indication: the strongest and most durable evidence is in pediatric ADHD (attention, inhibitory control, working memory); adult ADHD and sleep/insomnia data are mixed. Provider quality and protocol matching to the goal drive outcomes. Alpha for relaxation, SMR for focus, alpha-theta for trauma. Consider home devices for maintenance.
    SG

    Dr. Sanjeev Goel

    Chief Medical Officer, Peak Human

    Latest Evidence

    2024-2026: what the newest meta-analyses show

    The strongest recent evidence is in childhood ADHD. A 2025 systematic review and meta-analysis in Scientific Reports pooled 17 randomized controlled trials (939 children) and found neurofeedback training significantly improved inhibitory control (p<0.0001) and working memory (p<0.05), with a borderline effect on global executive function. Gains were larger when total training exceeded about 1,260 minutes, and the improvements in working memory and inhibitory control were still present at follow-up. A 2026 network meta-analysis of 37 trials (2,922 children and adolescents) found digital interventions reduced inattention (SMD -0.44) and hyperactivity-impulsivity (SMD -0.26) versus control, and ranked neurofeedback highest of all digital approaches for reducing inattention (SUCRA 79.4%).

    The picture is more cautious beyond pediatric ADHD. A 2025 Lancet Psychiatry network meta-analysis of adult ADHD (113 RCTs) included only 10 small neurostimulation/neurofeedback trials and found non-pharmacological effects inconsistent across raters, with stimulants and atomoxetine remaining the most robustly supported short-term options. And a 2024 meta-analysis of 7 RCTs reported that surface neurofeedback did not outperform control conditions for self-perceived sleep quality or insomnia. Protocol specificity, adequate training dose, and provider quality appear to separate responders from non-responders.

    These are summaries of published research, not treatment claims. Neurofeedback outcomes vary by protocol, indication, and provider; evidence is strongest in pediatric ADHD and mixed elsewhere. Educational information, not medical advice - discuss with a qualified clinician.

    Network meta-analysis · 37 RCTs · 2,922 youth

    Digital ADHD interventions vs control - pooled effect sizes

    ← More negative SMD = greater symptom reduction

    Source: Mei et al., Frontiers in Psychiatry, 2026 (37 RCTs, 2,922 children & adolescents). Negative SMD = greater symptom reduction vs control. Executive-function CI crosses zero (not significant). Neurofeedback ranked highest (SUCRA 79.4%) among digital interventions for reducing inattention.

    Key references: Neurofeedback training for executive function in ADHD children: a systematic review & meta-analysis - Scientific Reports (2025) · Effectiveness of different digital interventions on ADHD symptoms in children & adolescents: a network meta-analysis - Frontiers in Psychiatry (2026) · Comparative efficacy of neurofeedback interventions for ADHD in children: a network meta-analysis - Brain and Behavior (2024) · Comparative efficacy & acceptability of interventions for ADHD in adults: a component network meta-analysis - Lancet Psychiatry (2025) · Neurofeedback to enhance sleep quality & insomnia: a meta-analysis of RCTs - Frontiers in Neuroscience (2024)

    Cost & Access

    Cost Range

    $$$

    Accessibility

    Specialty clinics

    Availability varies by location

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation